FDA.reportPublic FDA data

ertugliflozin 2.5 MG / metformin hydrochloride 500 MG Oral Tablet

RxCUI
1992693
RxNorm name
ertugliflozin 2.5 MG / metformin hydrochloride 500 MG Oral Tablet
Display name
ertugliflozin 2.5 MG / metformin hydrochloride 500 MG Oral Tablet
Full name
ertugliflozin 2.5 MG / metformin hydrochloride 500 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:13

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a6aeb99a-ce49-4125-90ce-642df3f1ebadertugliflozin 2.5 MG / metFORMIN hydrochloride 500 MG Oral Tablet [PSN] · ertugliflozin 2.5 MG / metformin hydrochloride 500 MG Oral Tablet [SCD]219These highlights do not include all the information needed to use SEGLUROMET safely and effectively. See full prescribing information for SEGLUROMET. SEGLUROMET ® (ertugliflozin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 201720241220
b0451c1c-2b3b-4032-bb49-157425686754ertugliflozin 2.5 MG / metFORMIN hydrochloride 500 MG Oral Tablet [PSN] · ertugliflozin 2.5 MG / metformin hydrochloride 500 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use SEGLUROMET safely and effectively. See full prescribing information for SEGLUROMET. SEGLUROMET ® (ertugliflozin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 201720221113